Merck Plans Wilmington, Delaware, Biologics Operations
05/23/2025
The investment will include the construction of a 470,000-square-foot biologics center of excellence, located at the Chestnut Run Innovation and Science Park, which will feature laboratory, manufacturing and warehouse capabilities. Operations are scheduled to begin by 2028.
“The decision to build a new biologics facility in Wilmington demonstrates our commitment to advancing U.S. manufacturing and partnering in communities where our employees live and work,” said Sanat Chattopadhyay, executive vice president and president, Merck Manufacturing Division. “As a hub for life science, research and development, and pharmaceutical manufacturing, CRISP offers unparalleled opportunities for future expansion.”
Merck, doing business as Merck Sharp & Dohme or MSD outside the U.S. and Canada, develops and produces medicines, vaccines, biologic therapies and animal health products. The company’s blockbuster products include cancer immunotherapy, anti-diabetic medications, and vaccines for HPV and chickenpox.
“This new site in Delaware is on the cutting edge of innovation, helping lead the way as we transform medicine and technology,” noted Delaware Gov. Matt Meyer. “Merck is pioneering the next generation of care right here in Wilmington, and they couldn’t have picked a better place to do it. The positive impact this will have on Wilmington and the state of Delaware is exciting, and this is just the beginning.”
Project Announcements
Baltimore Fabrication Expands York County, Pennsylvania, Manufacturing Operations
07/25/2025
Mueller Streamline Expands Wynne, Arkansas, Manufacturing Operations
07/25/2025
Hive Plastics Plans Iron County, Utah, Manufacturing Operations
07/25/2025
Sigma Stretch Film of Georgia Plans Columbus, Georgia, Operations
07/24/2025
Turkish-Based Kervan USA Expands Lehigh Valley, Pennsylvania, Operations
07/24/2025
Germany-Based Butting Plans Loxley, Alabama, Production Operations
07/24/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
In Focus: AI Is Changing Incentives Math
Q2 2025
-
Optimizing Your Rail-Served Transportation Network: Strategy Before Steel
Q2 2025
-
How to Choose the Right Site for Your Factory in 2025’s Volatile Landscape
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
Tariffs, Talent, and U.S. Expansion
Q3 2025
-
First Person: David Robey, Co-CEO of QTS Data Centers
Q2 2025